205 related articles for article (PubMed ID: 23403630)
1. Expression defect size among unclassified MLH1 variants determines pathogenicity in Lynch syndrome diagnosis.
Hinrichsen I; Brieger A; Trojan J; Zeuzem S; Nilbert M; Plotz G
Clin Cancer Res; 2013 May; 19(9):2432-41. PubMed ID: 23403630
[TBL] [Abstract][Full Text] [Related]
2. Functional testing strategy for coding genetic variants of unclear significance in MLH1 in Lynch syndrome diagnosis.
Hinrichsen I; Schäfer D; Langer D; Köger N; Wittmann M; Aretz S; Steinke V; Holzapfel S; Trojan J; König R; Zeuzem S; Brieger A; Plotz G
Carcinogenesis; 2015 Feb; 36(2):202-11. PubMed ID: 25477341
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive functional assessment of MLH1 variants of unknown significance.
Borràs E; Pineda M; Brieger A; Hinrichsen I; Gómez C; Navarro M; Balmaña J; Ramón y Cajal T; Torres A; Brunet J; Blanco I; Plotz G; Lázaro C; Capellá G
Hum Mutat; 2012 Nov; 33(11):1576-88. PubMed ID: 22736432
[TBL] [Abstract][Full Text] [Related]
4. Detailed characterization of MLH1 p.D41H and p.N710D variants coexisting in a Lynch syndrome family with conserved MLH1 expression tumors.
Pineda M; González-Acosta M; Thompson BA; Sánchez R; Gómez C; Martínez-López J; Perea J; Caldés T; Rodríguez Y; Landolfi S; Balmaña J; Lázaro C; Robles L; Capellá G; Rueda D
Clin Genet; 2015 Jun; 87(6):543-8. PubMed ID: 25060679
[TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome associated with two MLH1 promoter variants and allelic imbalance of MLH1 expression.
Hesson LB; Packham D; Kwok CT; Nunez AC; Ng B; Schmidt C; Fields M; Wong JW; Sloane MA; Ward RL
Hum Mutat; 2015 Jun; 36(6):622-30. PubMed ID: 25762362
[TBL] [Abstract][Full Text] [Related]
6. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of MLH1 missense variants identified in Lynch syndrome patients.
Andersen SD; Liberti SE; Lützen A; Drost M; Bernstein I; Nilbert M; Dominguez M; Nyström M; Hansen TV; Christoffersen JW; Jäger AC; de Wind N; Nielsen FC; Tørring PM; Rasmussen LJ
Hum Mutat; 2012 Dec; 33(12):1647-55. PubMed ID: 22753075
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
[TBL] [Abstract][Full Text] [Related]
9. Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.
Kosinski J; Hinrichsen I; Bujnicki JM; Friedhoff P; Plotz G
Hum Mutat; 2010 Aug; 31(8):975-82. PubMed ID: 20533529
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches in evaluation of pathogenicity of single-base exonic germline changes involving the mismatch repair genes MLH1 and MSH2 in diagnostics of Lynch syndrome.
Gerykova-Bujalkova M; Krivulcik T; Bartosova Z
Neoplasma; 2008; 55(6):463-71. PubMed ID: 18999873
[TBL] [Abstract][Full Text] [Related]
11. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
12. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the effect of unclassified variants identified in MMR genes using phenotypic features, bioinformatics prediction, and RNA assays.
Pérez-Cabornero L; Infante M; Velasco E; Lastra E; Miner C; Durán M
J Mol Diagn; 2013 May; 15(3):380-90. PubMed ID: 23523604
[TBL] [Abstract][Full Text] [Related]
14. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1.
Raevaara TE; Korhonen MK; Lohi H; Hampel H; Lynch E; Lönnqvist KE; Holinski-Feder E; Sutter C; McKinnon W; Duraisamy S; Gerdes AM; Peltomäki P; Kohonen-Ccorish M; Mangold E; Macrae F; Greenblatt M; de la Chapelle A; Nyström M
Gastroenterology; 2005 Aug; 129(2):537-49. PubMed ID: 16083711
[TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
16. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
[TBL] [Abstract][Full Text] [Related]
17. Classifying MMR variants: time for revised nomenclature in Lynch syndrome.
You YN; Vilar E
Clin Cancer Res; 2013 May; 19(9):2280-2. PubMed ID: 23532885
[TBL] [Abstract][Full Text] [Related]
18. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families.
Borràs E; Pineda M; Blanco I; Jewett EM; Wang F; Teulé A; Caldés T; Urioste M; Martínez-Bouzas C; Brunet J; Balmaña J; Torres A; Ramón y Cajal T; Sanz J; Pérez-Cabornero L; Castellví-Bel S; Alonso A; Lanas A; González S; Moreno V; Gruber SB; Rosenberg NA; Mukherjee B; Lázaro C; Capellá G
Cancer Res; 2010 Oct; 70(19):7379-91. PubMed ID: 20858721
[TBL] [Abstract][Full Text] [Related]
19. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).
Chao EC; Velasquez JL; Witherspoon MS; Rozek LS; Peel D; Ng P; Gruber SB; Watson P; Rennert G; Anton-Culver H; Lynch H; Lipkin SM
Hum Mutat; 2008 Jun; 29(6):852-60. PubMed ID: 18383312
[TBL] [Abstract][Full Text] [Related]
20. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
